An ependymoma is an uncommon tumour that starts in the lining of the brain's fluid spaces and the spinal cord. This page explains what it is, the types, and how it is treated.
An ependymoma is a tumour that begins in the ependymal cells — the thin layer of cells that line the fluid-filled spaces of the brain (the ventricles) and the central canal of the spinal cord. It belongs to the wider family of gliomas, the tumours that start in the brain's support cells rather than spreading there from another organ.
Ependymomas are uncommon. What matters most is where the tumour sits and what grade it is, because both shape the symptoms and the treatment plan. This page sits within our wider brain cancer & tumour hub and explains, in plain language, what ependymomas are in adults, the main types, how they are graded, and how they are diagnosed and treated.
In adults, ependymomas most commonly arise in the spinal cord, while in children they more often arise inside the brain — particularly the posterior fossa near the cerebellum. This age difference matters: it changes the symptoms, the surgery, and the follow-up. The 2021 WHO classification of brain tumours (reflected in NCCN and EANO guidance) groups ependymomas by both their location and their molecular profile, so two tumours that look similar under the microscope can be classified, and treated, differently.
Ependymomas are grouped by their grade, their location, and — increasingly — their molecular profile. The type tells your team how the tumour is likely to behave and shapes the whole treatment plan.
A very slow-growing, benign tumour, often found by chance on a scan done for another reason. Many are small and cause no symptoms. When they do not cause problems, they may simply be monitored; when they do, complete surgery is usually curative.
A slow-growing tumour that arises almost exclusively at the lower end of the spinal cord in adults. The mainstay of treatment is complete surgical removal, which offers the best chance of long-term control; radiation may be added if removal is incomplete.
The most common form in adults, arising in the spinal cord or brain. Treatment centres on maximum safe surgery, often followed by radiation therapy depending on how completely the tumour was removed and where it sits.
A faster-growing, more aggressive form. It is treated with surgery followed by radiation, and is reviewed closely by the tumour board. Molecular subtyping is especially useful here to confirm the diagnosis and guide follow-up.
Because adult ependymomas so often arise in the spinal cord, this location deserves its own mention. Spinal ependymomas can cause back or neck pain, numbness or weakness, and are usually managed with surgery aimed at complete removal.
In children, ependymomas more often arise in the brain and are managed differently from adults. These are cared for under our pediatric cancer service — see our dedicated ependymoma in children page for a parent-focused guide.
Like other brain and spinal tumours, ependymomas are not given the Stage I–IV number most people associate with cancer. Instead they are given a WHO grade from 1 to 3, based on how the tumour cells look under the microscope and — since the 2021 WHO classification — on their molecular profile. The grade, not a stage, tells your team how urgent treatment is and which combination of treatments is needed.
Because the modern diagnosis combines grade, location and molecular biology, an accurate tissue diagnosis is essential. A brain tumor specialist will use all three to plan treatment. Speak to a CION neuro-oncologist to understand what your tumour type and grade mean.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Whether you want to understand your MRI, confirm the exact ependymoma type and grade, or get a second opinion before treatment — CION's neuro-oncology team is here to help, with same-week appointments.
The symptoms of an ependymoma depend almost entirely on where it grows, because different parts of the brain and spinal cord control different functions. Importantly, none of these symptoms means a tumour on its own — back pain, headaches and tingling are extremely common and usually have other, benign causes. What matters is a symptom that is new, persistent and progressive.
Red flag: a first adult seizure, new one-sided weakness, speech loss, sudden vision change, or new loss of bladder or bowel control that is persistent and progressive always warrants urgent imaging. Speak to a CION neuro-oncologist if you or a loved one has these signs.
Diagnosing an ependymoma takes more than a single scan. The pathway confirms the tumour, identifies its exact type and grade, and reads its molecular biology so the right treatment can be chosen.
An MRI with contrast is the gold standard for finding and characterising an ependymoma. Because adult ependymomas so often arise in the spinal cord, the work-up usually includes an MRI of the whole spine as well as the brain. Imaging shows the tumour's location, size and relationship to critical structures — but it can only suggest an ependymoma; it cannot confirm the exact type.
Only a tissue sample confirms an ependymoma, its type and its grade. Tissue is obtained during surgical removal of the tumour or, where needed, a biopsy. Both the biopsy and any neurosurgery are coordinated with accredited neurosurgical partners; CION manages the imaging, the laboratory and molecular testing, the radiation and the supportive care that follows.
This is where ependymoma classification has changed most. The 2021 WHO classification (reflected in NCCN and EANO guidance) groups ependymomas by both location and molecular profile — not by appearance under the microscope alone. Molecular subtyping helps confirm the exact diagnosis, refine the grade, and predict how the tumour is likely to behave, which in turn guides decisions about radiation and follow-up. CION arranges the relevant molecular testing on the surgical sample as standard. You can read more on our molecular testing for brain tumours page.
The 2021 WHO classification of central nervous system tumours (reflected in NCCN and EANO guidance) defines several molecular subtypes of ependymoma based on where the tumour sits and its genetic features — not just on how the cells look under the microscope. Two ependymomas that appear identical can belong to different molecular groups and behave very differently. This is exactly why a tumour board reviews each case and why molecular testing should be part of the standard work-up — if it has not been arranged, it is reasonable to ask for it.
There is no single treatment for "an ependymoma" — the plan depends on the grade, location, molecular subtype and how completely the tumour can be removed. What stays the same is that CION reviews every case at a multidisciplinary tumour board before any plan is finalised, and coordinates each step as one continuous journey.
What CION delivers directly: radiation therapy (IMRT/IGRT), systemic drug therapy, imaging and diagnosis, molecular testing, steroid and supportive care, and rehabilitation support. Specialist radiosurgery and neurosurgery are arranged through coordinated, accredited partners. For the full picture, see our brain tumor treatment in Hyderabad page. To see how ependymoma sits within the wider family, read about glioma.
An ependymoma diagnosis raises a lot of questions, and it is normal to feel overwhelmed. You deserve time to understand what is happening and to feel confident in the plan. At CION, every case is reviewed by a tumour board — surgery, radiation and medical oncology deciding together — and we make decisions for healing, not billing, with transparent costs explained up front.
A second opinion is particularly worthwhile in three situations:
To go deeper, read how ependymoma fits within the glioma family, and — if a child is affected — our parent-focused ependymoma in children guide. You can also explore our broader brain tumor treatment in Hyderabad page.
Ready to talk it through? Book a free consultation or call 18002028726 — we'll walk this journey with you.
Get a free written second opinion from CION's neuro-oncology tumour board — especially valuable before treatment begins, or if molecular subtyping of the tumour hasn't yet been arranged.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.An ependymoma is a tumour that arises from ependymal cells — the cells that line the fluid-filled spaces of the brain (the ventricles) and the central canal of the spinal cord. It is a type of glioma, the family of tumours that begins in the brain's support cells. Ependymomas can grow anywhere along this lining, but in adults they most often appear in the spinal cord, whereas in children they more often appear in the brain. They are uncommon, and the exact type and grade are confirmed by surgery or biopsy and laboratory testing — not by a scan alone.
Location is one of the biggest differences between adults and children. In adults, ependymomas most commonly arise in the spinal cord, and less often in the brain. In children, they more often arise inside the brain — particularly in the back of the brain (the posterior fossa) near the cerebellum and brainstem. Where the tumour sits shapes the symptoms and the treatment plan, which is why an accurate MRI of the brain and spine is part of the work-up. Childhood ependymomas are managed under our pediatric cancer service and our ependymoma in children page.
Ependymomas are graded by the World Health Organization on a scale of Grade 1 to Grade 3 rather than staged like other cancers, because they rarely spread outside the brain and spinal cord. Grade 1 ependymomas (such as myxopapillary ependymoma and subependymoma) grow very slowly and can often be controlled or cured with complete surgery. Grade 2 and Grade 3 ependymomas grow faster and behave more aggressively, and usually need radiation after surgery. So an ependymoma can range from a slow-growing tumour to one that needs combined treatment — the grade and the molecular profile tell your team how it is likely to behave.
Symptoms depend entirely on where the tumour grows, and most are caused by something other than a tumour. A spinal ependymoma (common in adults) may cause back or neck pain, numbness, weakness in the arms or legs, or changes in bladder or bowel control. A brain ependymoma can block the flow of cerebrospinal fluid and cause new, persistent and progressive headaches, nausea or vomiting (especially in the morning), and balance problems. None of these symptoms means a tumour on its own — but a symptom that is new, persistent and progressive warrants a scan. A first-ever adult seizure or new one-sided weakness always needs urgent imaging.
Diagnosis starts with an MRI with contrast of the brain and, because adult ependymomas often sit in the spine, frequently the whole spine as well. Imaging shows the tumour's location, size and features — but it can only suggest an ependymoma. A tissue sample from surgery or biopsy is needed to confirm the type and grade, and modern classification (per the 2021 WHO scheme reflected in NCCN and EANO guidance) also uses molecular markers to define ependymoma subtypes. At CION, surgery and biopsy are coordinated with accredited neurosurgical partners, while we manage the imaging, molecular testing, radiation and supportive care directly.
The cornerstone of treatment is maximum safe surgical removal, because the amount of tumour safely removed is one of the strongest predictors of outcome. This neurosurgery is coordinated with accredited neurosurgical partners. After surgery, radiation therapy (IMRT/IGRT) is often given for Grade 2 and Grade 3 tumours, or when the tumour could not be fully removed — CION delivers this directly. Chemotherapy has a smaller, case-by-case role in ependymoma and is considered by the tumour board. Some completely removed Grade 1 tumours are followed with surveillance MRI instead of immediate radiation. Every case is reviewed by a multidisciplinary tumour board.
The outlook varies a great deal and there is no single survival figure, because it depends on the grade, location, molecular subtype, and how completely the tumour was removed. In general, adult spinal ependymomas — especially low-grade tumours that are completely removed — tend to have a favourable long-term outlook, while higher-grade brain ependymomas behave more aggressively. Published ranges from sources such as NCCN and EANO are best discussed in the context of your specific tumour, framed sensitively and never as a guarantee. The most reliable way to understand your own outlook is a conversation with your neuro-oncology team after the tumour type, grade and extent of removal are known.
Browse our complete guide to brain tumours and brain cancer — symptoms, scans, tumour types, treatment, prognosis and life after treatment. Tap any topic to read more.